Literature DB >> 21734165

Endometrial cancer.

Srdjan Saso1, Jayanta Chatterjee, Ektoras Georgiou, Anthony M Ditri, J Richard Smith, Sadaf Ghaem-Maghami.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21734165     DOI： 10.1136/bmj.d3954

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  47 in total

1.  The important application of thioridazine in the endometrial cancer.

Authors:  Qiong Meng; Xiao Sun; Jing Wang; Yudong Wang; Lihua Wang
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?

Authors:  Rajani Bharati; Mark A Jenkins; Noralane M Lindor; Loïc Le Marchand; Steven Gallinger; Robert W Haile; Polly A Newcomb; John L Hopper; Aung Ko Win
Journal:  Gynecol Oncol       Date:  2014-03-11       Impact factor: 5.482

3.  Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis.

Authors:  Thomas Papathemelis; S Scharl; K Kronberger; M Gerken; A Scharl; A Pauer; M Klinkhammer-Schalke
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-24       Impact factor: 4.553

4.  Epigenetic changes as prognostic predictors in endometrial carcinomas.

Authors:  Sanja A Farkas; Bengt G Sorbe; Torbjörn K Nilsson
Journal:  Epigenetics       Date:  2016-11-22       Impact factor: 4.528

Review 5.  Use of fertility medications and cancer risk: a review and update.

Authors:  Lindsay Kroener; Daniel Dumesic; Zain Al-Safi
Journal:  Curr Opin Obstet Gynecol       Date:  2017-08       Impact factor: 1.927

6.  Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer.

Authors:  Jeffery M Vahrenkamp; Chieh-Hsiang Yang; Adriana C Rodriguez; Aliyah Almomen; Kristofer C Berrett; Alexis N Trujillo; Katrin P Guillen; Bryan E Welm; Elke A Jarboe; Margit M Janat-Amsbury; Jason Gertz
Journal:  Cell Rep       Date:  2018-03-13       Impact factor: 9.423

7.  Endometrial cancer arising from atypical complex hyperplasia: The significance in an endometrial biopsy and a diagnostic challenge.

Authors:  Jung Mi Byun; Dae Hoon Jeong; Young Nam Kim; En Bee Cho; Ju Eun Cha; Moon Su Sung; Kyung Bok Lee; Ki Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2015-11-16

8.  Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.

Authors:  Gennady Margolin; Hanna M Petrykowska; Nader Jameel; Daphne W Bell; Alice C Young; Laura Elnitski
Journal:  J Mol Diagn       Date:  2016-02-05       Impact factor: 5.568

9.  Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis.

Authors:  Thomas Papathemelis; Dunja Hassas; Michael Gerken; Monika Klinkhammer-Schalke; Anton Scharl; Michael P Lux; Mathias W Beckmann; Sophia Scharl
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-23       Impact factor: 4.553

10.  Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.

Authors:  Min Li; Yuan-Yue Li; Xiao-Yan Xin; Ying Han; Ting-Ting Wu; Hong-Bo Wang
Journal:  Tumour Biol       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.